Companies › GDTC

CYTOMED THERAPEUTICS LIMITED (GDTC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001873093 · EDGAR filings · Updated 2026-07-24

CYTOMED THERAPEUTICS LIMITED (GDTC) has reported institutional ownership of 0.1%, with 3 institutional managers holding positions valued at $16.3K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-24 — 4/A filed
• 2026-07-24 — SCHEDULE 13D/A filed
• 2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-23 — Foreign issuer report (6-K) filed
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-03 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CYTOMED THERAPEUTICS LIMITED has 3 institutional holders and institutional ownership of 0.1%.

Data flags from SEC filings

Related companies

EUDA HEALTH HOLDINGS LTD (EUDA) · BON NATURAL LIFE LIMITED (BON) · ADITXT INC (ADTX) · CHINA PHARMA HLDGS INC (CPHI) · BIOTRICITY INC (BTCY) · SYNLOGIC INC (SYBX)